TENAPANOR HYDROCHLORIDE

Search structure
Trade Names:
Synonyms:
Status: Approved (2019)
Entry Type: Small molecule
Molecule Category: Salt
UNII: 50605O2ZNS
Parent Compound: TENAPANOR

Structure
InChI Key VFRAXTZDILCRKY-OWRGXFNZSA-N
Smile CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1.Cl.Cl
InChI
InChI=1S/C50H66Cl4N8O10S2.2ClH/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54;;/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64);2*1H/t43-,44-;;/m0../s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C50H68Cl6N8O10S2
Molecular Weight 1217.99
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Sodium/hydrogen exchanger 3 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Irritable Bowel Syndrome 4 D043183 FDA
Renal Insufficiency, Chronic 2 D051436 ClinicalTrials
Hyperphosphatemia 2 D054559 ClinicalTrials

Related Entries

Scaffolds

Parent

Cross References

Resources Reference
ChEMBL CHEMBL3301627
FDA SRS 50605O2ZNS
PubChem 78131177
CONTENTS